Oroxylum indicum

Oroxylum indicum contains a suite of flavonoids — principally baicalein, chrysin, oroxylin A, baicalin, and oroxin A-D — that exert antioxidant, anti-inflammatory, antimicrobial, and anticancer effects through free radical scavenging, metal chelation, and modulation of inflammatory mediators. Preclinical in vitro studies demonstrate dose-dependent radical scavenging and antiglycation activity in stem bark ethanol extracts, and the plant is traditionally employed in Burmese medicine as a first-line remedy for diarrhea, though no human clinical trial data currently substantiate these effects with quantified effect sizes.

Origin & History

Oroxylum indicum is a deciduous tree native to Southeast Asia, distributed across India, Myanmar, Thailand, Malaysia, the Philippines, and southern China, typically growing in tropical and subtropical forests, forest margins, and disturbed areas up to 1,200 meters elevation. It thrives in well-drained loamy soils under humid, warm conditions and is commonly found along riverbanks and roadsides. The tree has been cultivated in traditional homegardens across Myanmar, India, and Thailand for its edible young pods, medicinal bark, and seeds.

Historical & Cultural Context

Oroxylum indicum has been documented in Ayurvedic medicine under the Sanskrit name 'Shyonaka,' where it figures as one of the ten roots comprising the classical Dashamula formulation, used for respiratory, rheumatic, and digestive conditions for over two millennia. In Burmese traditional medicine, stem bark preparations are a recognized treatment for diarrhea and gastrointestinal complaints, while in Thai traditional medicine the plant — known as 'Pheka' — is employed for liver ailments, fever, and skin diseases. Chinese traditional medicine utilizes the seeds under the name 'Mu Hu Die' (木蝴蝶), prescribing them for coughs, throat inflammation, and liver and stomach disorders, and the flat, winged seeds have long been used as a cultural ornamental element. The plant's wide geographic distribution and multipurpose use across distinct Asian medical traditions, combined with its culinary role in Southeast Asian cooking, reflect its deep integration into the material culture and healing practices of the region.

Health Benefits

- **Antioxidant Activity**: Stem bark ethanol extracts exhibit dose-dependent free radical scavenging and metal-chelating activity, with reducing power and total antioxidant capacity measured as quercetin equivalents in in vitro assays, attributed primarily to phenolic flavonoids such as baicalein and chrysin.
- **Anti-inflammatory Effects**: Flavonoids including baicalein and oroxylin A are associated with suppression of pro-inflammatory signaling, with stem bark extracts demonstrating anti-inflammatory potential in preclinical models, though specific cytokine targets have not yet been fully characterized in published results.
- **Antimicrobial Properties**: Leaf extracts have shown activity against gram-negative Pseudomonas aeruginosa and gram-positive Bacillus subtilis in vitro, with phytochemical screening identifying flavonoids, tannins, and phenols as the likely antimicrobial constituents contributing to this activity.
- **Hepatoprotective Potential**: Baicalein, one of the dominant flavonoids in Oroxylum indicum, is associated with liver protection through antioxidant mechanisms and reduction of oxidative stress-induced hepatocellular damage, as documented in preclinical studies of baicalein-rich plant sources.
- **Anticancer Activity**: Multiple flavonoids present in Oroxylum indicum — including baicalein, chrysin, and oroxylin A — have demonstrated antiproliferative effects against various cancer cell lines in preclinical research, with mechanisms proposed to involve apoptosis induction and cell cycle arrest.
- **Antiglycation Effects**: Stem bark extracts exhibit antiglycation potential relevant to diabetes management, suggesting that the plant's phenolic content may inhibit advanced glycation end-product (AGE) formation, a key contributor to diabetic complications.
- **Traditional Antidiarrheal Use**: In Burmese traditional medicine, stem bark preparations are employed to treat diarrhea, likely reflecting the astringent tannin content and antimicrobial flavonoids that may reduce intestinal inflammation and pathogen load, though formal clinical validation is lacking.

How It Works

Oroxylum indicum's primary flavonoids — baicalein, chrysin, oroxylin A, and their glycoside forms baicalin and oroxin A-D — exert antioxidant effects through direct hydrogen atom donation to free radicals (DPPH, ABTS) and chelation of transition metal ions (Fe²⁺, Cu²⁺) that would otherwise catalyze lipid peroxidation via Fenton-type reactions, thereby protecting cellular membranes from oxidative damage. Baicalein and oroxylin A are known in broader phytochemical literature to inhibit NF-κB and COX-2 pathways, reducing the transcription of pro-inflammatory cytokines such as TNF-α and IL-6, though specific pathway data for Oroxylum indicum extracts remain undercharacterized in published research. Chrysin exhibits inhibitory effects on aromatase (CYP19A1) and has been associated with modulation of the PI3K/Akt/mTOR signaling cascade in cancer cell models, contributing to the antiproliferative effects observed in vitro. Tannins and phlobatannins present in stem bark and leaf extracts further contribute astringent and protein-precipitating actions relevant to antidiarrheal and antimicrobial activities through disruption of microbial cell membranes and inhibition of bacterial adhesion.

Scientific Research

The current body of evidence for Oroxylum indicum is confined entirely to in vitro and phytochemical characterization studies, with no published human clinical trials reporting sample sizes, randomization, or quantified clinical outcomes. In vitro antioxidant studies using stem bark ethanol extracts demonstrate dose-dependent reducing power and total antioxidant capacity expressed as quercetin equivalents, and antimicrobial assays confirm inhibitory activity against P. aeruginosa and B. subtilis from leaf extracts. Endophytic fungal extracts isolated from Oroxylum indicum leaves (notably OI-L6, showing 55.16 μg GAE/mg total phenolic content, and OI-L8 at 26.52 μg GAE/mg) have been characterized by HPTLC, adding complexity to the plant's bioactive landscape but without in vivo or clinical corroboration. The evidence base is preliminary and insufficient to establish efficacy, dosing, or safety in humans; most data derive from small-scale laboratory experiments and should be interpreted with significant caution.

Clinical Summary

No human clinical trials have been conducted or published for Oroxylum indicum as of the most recent available data, meaning there are no randomized controlled trials, cohort studies, or case series from which to draw effect sizes, confidence intervals, or clinical recommendations. The clinical relevance of the plant is currently inferred from traditional ethnomedicinal use — particularly its antidiarrheal application in Burmese medicine — and from in vitro preclinical data demonstrating antioxidant, antimicrobial, antiglycation, and antiproliferative activities. Individual flavonoids present in the plant, especially baicalein and chrysin, have been more extensively studied in isolation through in vitro and animal models, offering mechanistic plausibility but not direct clinical evidence for Oroxylum indicum preparations specifically. Confidence in clinical outcomes is very low; the plant remains a candidate for future pharmacological investigation rather than an evidence-based therapeutic agent.

Nutritional Profile

Oroxylum indicum is principally characterized by its flavonoid content rather than conventional macronutrient density, with baicalein, baicalin, chrysin, oroxylin A, and the oroxin glycoside series (oroxin A–D) constituting the primary bioactive phytochemicals; absolute tissue concentrations in the plant have not been precisely quantified in the reviewed literature. Stem bark ethanol extracts contain alkaloids, glycosides, tannins, and flavonoids, while leaf extracts yield phlobatannins, phenols, flavonoids, tannins, and glycosides but notably lack terpenoids by phytochemical screening. Ursolic acid, a pentacyclic triterpenoid with anti-inflammatory and metabolic properties, has also been identified. The young edible pods contribute dietary fiber, vitamins, and minerals typical of leguminous vegetables, though precise micronutrient assays for the pods are not well-documented in the available literature. Flavonoid bioavailability from plant matrices is generally influenced by glycosylation status — glycosides such as baicalin require intestinal deglycosylation before absorption, potentially limiting bioavailability compared to aglycone forms like baicalein.

Preparation & Dosage

- **Traditional Stem Bark Decoction (Burmese/Southeast Asian)**: Bark is boiled in water and consumed as a tea for diarrhea; no standardized dose is established, but folk practice typically uses 5–10 grams of dried bark per preparation.
- **Ethanol Stem Bark Extract (Research Grade)**: Used in preclinical studies for antioxidant and antiglycation assessment; no human-applicable dose has been derived from these investigations.
- **Leaf Poultice or Infusion**: Fresh or dried leaves are prepared as infusions or topical poultices in traditional antimicrobial applications across South and Southeast Asian medicine systems.
- **Edible Young Pods (Culinary Use)**: Immature seed pods are consumed as a vegetable in Thai, Indian, and Burmese cuisines, representing a dietary form with incidental flavonoid intake.
- **Standardization**: No commercial supplement standardization (e.g., percentage baicalein or chrysin) has been established for Oroxylum indicum extracts specifically.
- **Dosage Note**: Effective supplemental doses for humans have not been determined through clinical trials; all dosing references remain based on traditional use or in vitro research concentrations not directly translatable to human equivalents.

Synergy & Pairings

Oroxylum indicum's baicalein content is known in the broader phytochemical literature to act synergistically with quercetin and other flavonoids in combined antioxidant preparations, as their complementary radical scavenging mechanisms (hydrogen atom transfer vs. single electron transfer) provide broader protection against oxidative stress than either compound alone. In Ayurvedic formulations such as Dashamula, Oroxylum indicum is combined with other roots including Aegle marmelos and Premna integrifolia, with the rationale that the combined anti-inflammatory and adaptogenic effects of the root complex exceed individual component activity. The tannin-flavonoid combination within Oroxylum indicum's own bark extract may exhibit internal synergy for antidiarrheal applications, as tannins provide astringent gut-lining protection while flavonoids address the antimicrobial and anti-inflammatory components of infectious diarrhea.

Safety & Interactions

Formal safety data for Oroxylum indicum preparations in humans are absent from the published literature; no dose-ranging toxicity studies, adverse event reporting from clinical trials, or established tolerable upper intake levels exist for this plant or its extracts. The individual flavonoids baicalein and chrysin, when studied in isolation at high doses in preclinical models, have been associated with potential endocrine-modulating effects (particularly chrysin's aromatase inhibition), which raises theoretical concerns for use in individuals with hormone-sensitive conditions, though this has not been demonstrated specifically for whole Oroxylum indicum extracts. Drug interaction data are not available, but the presence of potent CYP450-modulating flavonoids (baicalein is known to interact with CYP1A2, CYP2C9, and CYP3A4 in preclinical models) suggests a theoretical risk of pharmacokinetic interactions with drugs metabolized by these enzymes, including anticoagulants, antiepileptics, and immunosuppressants. Oroxylum indicum is not recommended during pregnancy or lactation due to complete absence of safety data, and its historical use as a medicinal plant does not substitute for evidence-based safety assessment in vulnerable populations.